Cedars-Sinai Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Cedars-Sinai Medical Center sits in the top decile of US sponsors by registered trial count (#106 of 15,742 sponsors by registered trial count).
Cedars-Sinai Medical Center: 339 sponsored US clinical trials, 70 recruiting.
Cedars-Sinai Medical Center sponsors 339 registered US clinical trials on ClinicalTrials.gov, 70 of them currently recruiting, and 180 completed. 42 of these trials are in Phase 3-4 (later-stage) and 83 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bladder Cancer, with 6 trials.
Top-decile sponsor footprint
Cedars-Sinai Medical Center ranks in the top decile of sponsors by registered trial count (#106 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
180 of 230 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
339 total, page 3 of 7
Precise Cooler for Donor Heart Transport
NCT07354763
A Nutritional Intervention for Body, Brain, and Longevity Effects (NIBBLE)
NCT06682767
Bupivacaine With Epinephrine Over Diaphragm in Laparoscopy
NCT07400146
Digital Inhaler Use in Obstructive Lung Disease Care
NCT07214337
Improving Sexual Health in Gynecological Cancer Patients
NCT07144566
Evaluating the Efficiency and Tolerability of the Oxygenating Bite Block
NCT07086378
Artificial Intelligence Powered Mental Health Support Tool For Physicians In Training
NCT07087119
Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation
NCT07034443
Ostomy Readmission Reduction Program
NCT06956274
Implementing Music Therapy for Video-Assisted Thoracoscopic Surgery Patients: A Quality Improvement Initiative
NCT06778720
Implementation of a Pharmacist-Based, Post-Chemotherapy Follow-up Clinic
NCT05965206
Using Mirabegron to Increase BP in Patients With POTS
NCT06133075
Propofol + Remifentanil vs. Propofol + Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Having Spine Surgery
NCT06096181
Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantation for Multiple Myeloma
NCT05961215
Elemental Diet and Gut Microbiome
NCT05978973
A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF
NCT04907825
Lower Extremity BFR-randomized Controlled Trial Healthy Volunteers
NCT05868304
Remote Weight Management Program for Obese Women
NCT05635097
Elders Preserving Independence in the Community
NCT05381480
Distal Targeter vs Free-hand
NCT05613257
Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial
NCT05403736
Integrative Self-care Approaches for HCP Wellbeing
NCT05387746
Pilot Study of Posaconazole in Crohn's Disease
NCT04966585
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
NCT05131815
MiVacunaLA: an Intervention to Improve COVID-19 Vaccination Behaviors Among Latinos
NCT05234372
Cognitive Training Through Gaming and Walking
NCT04638413
Trial to Compare the SherpaPak™ Device vs Cold Storage
NCT05194514
Behavioral Economics to Improve Antihypertensive Therapy Adherence
NCT04029883
Safety and Efficacy Study of AI LVEF
NCT05140642
Pragmatic Comparative Effectiveness Trial of Evidence-based, On-demand, Digital Behavioral Treatments for Chronic Pain
NCT04933474
Remote Monitoring and Follow-up for Postpartum Hypertensive Disorders of Pregnancy
NCT05124327
Using Electrical Nerve Stimulation to Control Atrial Fibrillation
NCT04529941
Substance Use Treatment and Recovery Team
NCT05086796
Stepping Up: A Trial of Activity Monitoring Devices in Patients Undergoing Autologous Stem Cell Transplant
NCT04985409
Does Limb Pre-Conditioning Reduce Pain After Hip Arthroscopy
NCT04925791
Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes
NCT04899778
Complement Regulation to Undo Systemic Harm in Preeclampsia
NCT04725812
Inhibitory Control and Pediatric Weight Management
NCT04747548
IIT2020-20-SHIRAZIP-WALK: Nature Walks
NCT04896580
Alexa, What is Eliquis and Xarelto?
NCT04790773
Improving Female Sexual Wellness
NCT04824820
Inhibitory Control Adult Weight Management
NCT04747886
Berinert (C1INH) vs Placebo for DGF/IRI
NCT04696146
Radiogenomics of Muscle Invasive Bladder Cancer
NCT04806334
Tofacitinib For Treatment Of Chronic Pouchitis
NCT04580277
Efficacy and Safety of Rifaximin With NAC in IBS-D
NCT04557215
UVA Light Device to Treat COVID-19
NCT04572399
Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic
NCT04652674
Virtual Reality Therapy for Chronic Low Back Pain
NCT04409353
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
NCT04558125
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 43 |
| Phase 2 | 40 |
| Phase 3 | 9 |
| Phase 4 | 33 |
What is open in the Cedars-Sinai Medical Center pipeline
70 recruiting of 339 indexed (21% open); 180 completed (53%).
Phase mix: 42 late (III/IV) vs 83 early (I/II) (early-phase heavy).
Top condition: Bladder Cancer (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Cedars-Sinai Medical Center: open-pipeline peers nationwide
Peers matched on 339 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
Cedars-Sinai Medical Center sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 339 trials (± recruiting share)
- National Institutes of Health Clinical Center (CC) · 338 trials · 7% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
- Children's Oncology Group · 342 trials · 10% recruiting
- National Institute of Mental Health (NIMH) · 343 trials · 12% recruiting
Sponsors near 21% open enrollment (± trial volume)
- University of Colorado, Denver · 21% recruiting · 1,283 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this Cedars-Sinai Medical Center page
339 registered trials is a research-attention snapshot, not an endorsement of Cedars-Sinai Medical Center or any single study.
- 70 of Cedars-Sinai Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bladder Cancer is the condition Cedars-Sinai Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bladder Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Cedars-Sinai Medical Center pipeline card: 339 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.